Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12264167
Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors
granted -
US 12263225
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of use thereof to target dystrophin and to treat Duchenne muscular dystrophy
granted -
US 12263179
Lyme disease-associated T cell receptor-related methods
granted -
US 12264149
Indazole compounds as kinase inhibitors
granted -
US 12264345
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12263148
Levodopa dosing regimen
granted -
US 12263149
Levodopa dosing regimen
granted -
US 12263145
Methods of administering solriamfetol to lactating women
granted -
US 12263165
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
granted -
TW 202513047
KAT6 inhibitors
granted -
US 12263169
Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
granted -
US 12266425
T cell receptor sequences diagnostic for COVID-19 and related compositions
granted -
US 12263156
Use of small molecule inhibitors of the BfrB:Bfd interaction in biofilms
granted -
US 12264154
Compounds and methods of use
granted -
US 12264169
Heteroaryl inhibitors of PDE4
granted -
US 12263180
Method for treatment of COVID-19-associated conditions
granted -
WO 2025064824
MÉTHODES DE TRAITEMENT DE LA MALADIE D'ALZHEIMER
granted -
WO 2025062334
DÉRIVÉS DE 4-((5-(3-(4-(PYRIDIN-2-YL)CYCLOPENTYL)-1 H-PYRAZOL-3-YL)AMINO)-BENZÈNESULFONAMIDE ET COMPOSÉS SIMILAIRES UTILISÉS COMME INHIBITEURS DE CDK POUR LE TRAITEMENT DU CANCER
granted -
AR 131518
COMPUESTO DE 4-AMINOPIPERIDINA, NANOPARTÍCULAS LIPÍDICAS DEL MISMO Y COMPOSICIÓN FARMACÉUTICA QUE CONTIENE EL MISMO
granted -
US 12258317
Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof
granted -
US 12257261
Preparation of preliposomal Annamycin lyophilizate
granted -
US 12258341
IRAK degraders and uses thereof
granted -
US 12257326
TCO conjugates and methods for delivery of therapeutic agents
granted -
US 12258370
Betulastatin compounds
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.